PlainRecalls
FDA Drug Critical Class I Terminated

8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx only, Manufactured and Distributed by: Exela Pharma Sciences, LLC Lenoir, NC 28645. Carton NDC 51754-5001-5, vial NDC 51754-5001-1.

Reported: December 21, 2022 Initiated: November 28, 2022 #D-0079-2023

Product Description

8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx only, Manufactured and Distributed by: Exela Pharma Sciences, LLC Lenoir, NC 28645. Carton NDC 51754-5001-5, vial NDC 51754-5001-1.

Reason for Recall

Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.

Details

Recalling Firm
Exela Pharma Sciences LLC
Units Affected
489,600 vials
Distribution
Nationwide within the United States
Location
Lenoir, NC

Frequently Asked Questions

What product was recalled?
8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx only, Manufactured and Distributed by: Exela Pharma Sciences, LLC Lenoir, NC 28645. Carton NDC 51754-5001-5, vial NDC 51754-5001-1.. Recalled by Exela Pharma Sciences LLC. Units affected: 489,600 vials.
Why was this product recalled?
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 21, 2022. Severity: Critical. Recall number: D-0079-2023.